tradingkey.logo
tradingkey.logo
Search

Cardiff Oncology Inc

CRDF
Add to Watchlist
0.855USD
+0.004+0.52%
Close 07-31 16:00ETQuotes delayed by 15 min
66.55MMarket Cap
LossP/E TTM

CRDF Financials

See Cardiff Oncology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cardiff Oncology Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.18/-0.13
Revenue / Forecast
41.00K/85.00K
Period
FY2025 Earnings
Revenue(YoY)
593.00K
-13.18%
EPS(YoY)
-0.69
28.05%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
10.56%-0.18
50.75%-0.11
33.45%-0.17
20.24%-0.21
9.89%-0.20
-4.01%-0.22
-16.13%-0.25
-5.28%-0.26
10.80%-0.22
-6.99%-0.21
---0.22
---0.25
---0.25
---0.20
----
----
----
----
----
----
Revenue
-62.39%41.00K
60.93%243.00K
-27.27%120.00K
-25.77%121.00K
-46.83%109.00K
-3.21%151.00K
17.02%165.00K
50.93%163.00K
146.99%205.00K
21.88%156.00K
51.61%141.00K
18.68%108.00K
12.16%83.00K
-3.76%128.00K
8.14%93.00K
33.82%91.00K
2.78%74.00K
11.53%133.00K
-36.95%86.00K
59.50%68.00K
Net Profit
8.10%-12.35M
38.75%-7.22M
5.03%-11.26M
-18.37%-13.95M
-34.17%-13.44M
-26.22%-11.79M
-21.81%-11.86M
-5.63%-11.78M
10.79%-10.02M
-7.35%-9.34M
-13.52%-9.74M
-6.77%-11.16M
-2.09%-11.23M
7.89%-8.70M
-23.96%-8.58M
-54.50%-10.45M
-112.13%-11.00M
-43.08%-9.45M
-53.67%-6.92M
8.57%-6.76M
Net Margin
-144.30%-30109.76%
61.96%-2969.55%
-30.58%-9381.67%
-59.47%-11523.14%
-152.38%-12324.77%
-30.42%-7805.96%
-4.11%-7184.85%
30.01%-7225.77%
63.88%-4883.41%
11.91%-5985.26%
---6901.42%
---10324.07%
---13521.69%
---6794.53%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Revenue
-62.39%41.00K
60.93%243.00K
-27.27%120.00K
-25.77%121.00K
-46.83%109.00K
-3.21%151.00K
17.02%165.00K
50.93%163.00K
146.99%205.00K
21.88%156.00K
51.61%141.00K
18.68%108.00K
12.16%83.00K
-3.76%128.00K
8.14%93.00K
33.82%91.00K
2.78%74.00K
11.53%133.00K
-36.95%86.00K
59.50%68.00K
Operating profit
10.65%-12.85M
37.74%-7.83M
4.98%-11.97M
-17.79%-14.78M
-31.55%-14.38M
-21.68%-12.57M
-16.46%-12.60M
-2.76%-12.54M
9.28%-10.93M
-10.01%-10.33M
-20.32%-10.82M
-16.90%-12.21M
-8.83%-12.05M
1.41%-9.39M
-28.51%-8.99M
-51.59%-10.44M
-103.49%-11.07M
-46.62%-9.53M
-60.41%-7.00M
-69.34%-6.89M
Net Profit
8.10%-12.35M
38.75%-7.22M
5.03%-11.26M
-18.37%-13.95M
-34.17%-13.44M
-26.22%-11.79M
-21.81%-11.86M
-5.63%-11.78M
10.79%-10.02M
-7.35%-9.34M
-13.52%-9.74M
-6.77%-11.16M
-2.09%-11.23M
7.89%-8.70M
-23.96%-8.58M
-54.50%-10.45M
-112.13%-11.00M
-43.08%-9.45M
-53.67%-6.92M
8.57%-6.76M
Current assets
-42.76%47.34M
-36.74%60.13M
4.16%61.80M
18.39%73.70M
18.18%82.71M
22.79%95.05M
-29.29%59.33M
-32.87%62.25M
-31.22%69.99M
-30.44%77.41M
-29.94%83.91M
-27.22%92.73M
-25.07%101.75M
-23.84%111.28M
-13.08%119.75M
-10.82%127.41M
5.63%135.81M
9.58%146.13M
260.76%137.77M
395.75%142.87M
Total current liabilities
8.82%14.46M
22.09%16.39M
17.41%14.71M
33.12%16.67M
12.23%13.29M
28.62%13.43M
38.89%12.53M
37.26%12.52M
45.35%11.84M
33.71%10.44M
9.38%9.02M
7.57%9.12M
22.27%8.15M
19.04%7.81M
63.53%8.24M
85.22%8.48M
48.78%6.66M
7.19%6.56M
-7.35%5.04M
-7.72%4.58M
Total assets
-42.02%49.17M
-36.33%61.88M
1.41%63.78M
14.67%75.74M
14.55%84.81M
19.05%97.19M
-28.89%62.90M
-32.22%66.05M
-30.51%74.04M
-29.74%81.64M
-28.45%88.45M
-25.75%97.45M
-23.46%106.55M
-22.30%116.19M
-12.51%123.63M
-8.68%131.26M
7.43%139.20M
11.00%149.54M
258.20%141.31M
377.06%143.73M
Total liabilities
3.82%14.46M
15.83%16.50M
11.00%14.99M
25.40%17.13M
5.99%13.93M
19.69%14.24M
27.10%13.50M
25.63%13.66M
30.84%13.14M
20.82%11.90M
1.98%10.63M
0.83%10.88M
10.37%10.05M
7.90%9.85M
34.13%10.42M
123.98%10.79M
91.38%9.10M
38.93%9.13M
31.04%7.77M
-16.17%4.82M
Total equity
-51.03%34.71M
-45.28%45.39M
-1.22%48.79M
11.87%58.61M
16.39%70.88M
18.94%82.95M
-36.54%49.39M
-39.49%52.39M
-36.90%60.89M
-34.42%69.74M
-31.26%77.83M
-28.13%86.58M
-25.83%96.50M
-24.27%106.34M
-15.22%113.21M
-13.28%120.47M
4.23%130.10M
9.57%140.42M
298.37%133.54M
469.71%138.92M
Net operating income
3.95%-12.29M
41.88%-5.97M
-3.62%-10.83M
9.77%-8.33M
-65.30%-12.79M
-43.82%-10.27M
-31.41%-10.46M
-29.42%-9.23M
10.61%-7.74M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-27.06%-9.39M
-36.98%-7.49M
-55.66%-6.70M
-74.18%-10.25M
-44.23%-7.39M
-55.02%-5.46M
-0.23%-4.30M
Net investment
122.33%3.26M
138.28%10.75M
207.70%10.16M
-135.55%-4.98M
-414.58%-14.58M
-66.74%4.51M
-346.90%-9.43M
22.04%14.02M
-36.74%4.64M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
179.83%7.02M
-35.86%5.16M
140.03%7.61M
116.44%18.36M
-15037.01%-8.79M
5333.96%8.05M
---19.00M
Net financing
3400.00%105.00K
-94.22%2.55M
-99.66%25.00K
-100.00%0.00
-97.20%3.00K
--44.19M
--7.43M
--2.06M
--107.00K
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
--75.00K
-100.00%0.00
-100.00%0.00
-85.00%14.96M
-100.00%0.00
-15.56%19.23M

FAQs

What is the total revenue of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its total revenue reached 593.00K, with a year-on-year change of 683.00K.

What are the current assets of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its current assets were 60.13M, with a year-on-year change of -36.74.

What are the total assets of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its total assets of Cardiff Oncology Inc were 61.88M, with a year-on-year change of -36.33.

What are the total liabilities of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its total liabilities of Cardiff Oncology Inc were 16.50M, with a year-on-year change of 15.83.

What is the total equity of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its total equity of Cardiff Oncology Inc was 45.39M, with a year-on-year change of -45.28.

What is the net operating income of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its net operating income of Cardiff Oncology Inc was -48.96M, with a year-on-year change of -0.64.

What is the net investment of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its net investment of Cardiff Oncology Inc was 1.34M, with a year-on-year change of -90.22.

What is the net financing of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its net financing of Cardiff Oncology Inc was 2.58M, with a year-on-year change of -95.20.

What is the Earnings Per Share (EPS) of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.69, with a year-on-year change of 28.05.

What is the net income of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its net income was -45.88M, with a year-on-year change of -0.93.

What is the net margin of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its net profit margin was -7732.04, with a year-on-year change of -16.24.

What is the Return on Equity (ROE) of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its Return on Equity (ROE) was -71.49, with a year-on-year change of -20.08.

What is the Return on Assets (ROA) of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its Return on Assets (ROA) was -57.65, with a year-on-year change of -13.46.

What is the operating profit of Cardiff Oncology Inc?

According to Cardiff Oncology Inc's FY2025 earnings report, its operating profit was -48.96M, with a year-on-year change of -0.64.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.